The role of small intestinal bacterial overgrowth in food intolerances Review article

Article Sidebar

PDF PDF (Język Polski)


Published: Apr 22, 2021
DOI: https://doi.org/10.24292/01.AP.172120321
Keywords:
SIBO, lactose intolernace, hydrogen breath test, FODMAP

Main Article Content

Natalia Ukleja-Sokołowska
Department of Allergology, Clinical Immunology and Internal Diseases, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń
http://orcid.org/0000-0001-5957-8382
Marcelina Bartuzi
Students’ Scientific Association of Allergology, Department of Allergology, Clinical Immunology and Internal Diseases, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń
http://orcid.org/0000-0003-1988-8348

Abstract

Food intolerances are increasingly common in populations of developed countries. One of the important factors in the etiopathogenesis of this phenomenon is disorders of the bacterial composition of the human gastrointestinal tract. The development of civilization as well as the increasing production of processed food contribute to the increased incidence of diseases of the digestive system, such as small intestinal bacterial overgrowth (SIBO)  and food intolerances. These conditions may occur separately or coexist in one patient. The incidence of food intolerances and also allergies, continues to increase. It is estimated that factors such as stress, inadequate lifestyle, excessive consumption of processed, modified foods may contribute to this phenomenon.


The article presents the relationship between bacterial overgrowth in the small intestine and the effect on various aspects of food intolerances, both in the context of diagnosis and the course of these diseases on the basis of recent research.   The nature od low-FODMAP diet was presented,  as well as its effect on the clinical course of SIBO and food intolerances.

Downloads

Download data is not yet available.

Article Details

How to Cite
Ukleja-Sokołowska, N., & Bartuzi , M. (2021). The role of small intestinal bacterial overgrowth in food intolerances. Alergoprofil, 17(2), 34-39. https://doi.org/10.24292/01.AP.172120321
Issue
Vol 17 No 2 (2021)
Section
THERAPY
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)

References

1. Savage J, Johns CB. Food allergy: epidemiology and natural history. Immunol Allergy Clin. 2015; 35(1): 45-59.
2. Ruscio M. Is SIBO A Real Condition? Altern Ther Health Med. 2019; 25(5): 30-8.
3. Crowe SE. Food allergy vs food intolerance in patients with irritable bowel syndrome. Gastroenterol Hepatol. 2019; 15(1): 38.
4. Tuck CJ, Biesiekierski JR, Schmid-Grendelmeier P et al. Food intolerances. Nutrients. 2019; 11(7): 1684.
5. Esposito S, Biscarini A, Federici B et al. Role of Small Intestinal Bacterial Overgrowth (SIBO) and Inflammation in Obese Children. Front Pediatr. 2020; 8: 369.
6. Pawlak K, Rudzik R, Lewiński M et al. Dieta L-FODMAP w leczeniu zespołu jelita drażliwego. Bromat Chem Toksykol. 2017; 2: 179-83.
7. Olszewska J, Jagusztyn-Krynicka EK. Human Microbiome Project – mikroflora jelit oraz jej wpływ na fizjologię i zdrowie człowieka. Post Mikrobiol. 2012; 51(4): 243-56.
8. Ghoshal UC, Shukla R, Ghoshal U. Small intestinal bacterial overgrowth and irritable bowel syndrome: a bridge between functional organic dichotomy. Gut Liver. 2017; 11(2): 196.
9. Paik CN, Choi MG, Lim CH et al. The role of small intestinal bacterial overgrowth in postgastrectomy patients. Neurogastroenterol Motil. 2011; 23(5): e191-6.
10. Avelar Rodriguez D, Ryan PM, Toro Monjaraz EM et al. Small intestinal bacterial overgrowth in children: a state-of-the-art review. Front Pediatr. 2019; 7: 363.
11. Adike A, DiBaise JK. Small intestinal bacterial overgrowth: nutritional implications, diagnosis, and management. Gastroenterol Clin. 2018; 47(1): 193-208.
12. Tordesillas L, Berin MC, Sampson HA. Immunology of food allergy. Immunity. 2017; 47(1): 32-50.
13. Mądry E, Krasińska B, Walkowiak J. Hipolaktazja, zespół złego wchłaniania laktozy, nietolerancja laktozy. Fam Med Prim Care Rev. 2011; 2: 334-6.
14. Braden B. Methods and functions: Breath tests. Best Pract Res Clin Gastroenterol. 2009; 23(3): 337-52.
15. Bartuzi Z, Ukleja-Sokołowska N. Alergia pokarmowa na mąkę i celiakia. Alergia. 2014; 2: 4-10.
16. Ukleja-Sokołowska N, Zacniewski R, Gawrońska-Ukleja E et al. Food-dependent, exercise-induced anaphylaxis in a patient allergic to peach. Int J Immunopathol Pharmacol. 2018; 32: 2058738418803154.
17. Szilagyi A, Ishayek N. Lactose intolerance, dairy avoidance, and treatment options. Nutrients. 2018; 10(12): 1994.
18. Coffee EM, Tolan DR. Mutations in the promoter region of the aldolase B gene that cause hereditary fructose intolerance. J Inherit Metab Dis. 2010; 33(6): 715-25.
19. Żelowski A, Wojtuń S, Gil J et al. Zespół jelita nadwrażliwego – podstawowe zasady rozpoznawania i leczenia. Pediatria i Medycyna Rodzinna. 2013; 9(3): 250-5.
20. Mehta M, Beg M. Fructose intolerance: cause or cure of chronic functional constipation. Glob Pediatr Health. 2018; 5: 2333794X18761460.
21. Yakoob J, Abbas Z, Khan R et al. Small intestinal bacterial overgrowth and lactose intolerance contribute to irritable bowel syndrome symptomatology in Pakistan. Saudi J Gastroenterol. 2011; 17(6): 371.
22. Zhao J, Fox M, Cong Y et al. Lactose intolerance in patients with chronic functional diarrhoea: the role of small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2010; 31(8): 892-900.
23. Houben E, De Preter V, Billen J et al. Additional value of CH4 measurement in a combined 13C/H2 lactose malabsorption breath test: a retrospective analysis. Nutrients. 2015; 7(9): 7469-85.
24. Varjú P, Ystad B, Gede N et al. The role of small intestinal bacterial overgrowth and false positive diagnosis of lactose intolerance in southwest Hungary – A retrospective observational study. PloS ONE. 2020; 15(5): e0230784.
25. Silva CD, Leite ID, Rodrigues JW et al. Analysis of lactose intolerance in students with suggestive symptoms of irritable bowel syndrome. Arq Gastroenterol. 2019; 56(3): 304-11.
26. Rana SV, Malik A, Bhadada SK et al. Malabsorption, orocecal transit time and small intestinal bacterial overgrowth in type 2 diabetic patients: a connection. Indian J Clin Biochem. 2017; 32(1): 84-9.
27. Perets TT, Hamouda D, Layfer O et al. Small intestinal bacterial overgrowth may increase the likelihood of lactose and sorbitol but not fructose intolerance false positive diagnosis. Ann Clin Lab Sci. 2017; 47(4): 447-51.
28. Wilder‐Smith CH, Olesen SS, Materna A et al. Predictors of response to a low‐FODMAP diet in patients with functional gastrointestinal disorders and lactose or fructose intolerance. Aliment Pharmacol Ther. 2017; 45(8): 1094-106.
29. Enko D, Kriegshäuser G, Kimbacher C et al. Carbohydrate malabsorption and putative carbohydrate-specific small intestinal bacterial overgrowth: prevalence and diagnostic overlap observed in an Austrian outpatient center. Digestion. 2015; 92(1): 32-8.
30. Hill P, Muir JG, Gibson PR. Controversies and recent developments of the low-FODMAP diet. Gastroenterol. Hepatol. 2017; 13(1): 36-45.
31. Cozma-Petruţ A, Loghin F, Miere D et al. Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients! World J Gastroenterol. 2017; 23(21): 3771-83.